✦ LIBER ✦

406 Interferon therapy improves prognosis in patients with HBeAg positive chronic hepatitis B

Book ID: 117373917
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 126 KB
Volume: 42
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)81818-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term results of interferon therapy

Long-term results of interferon therapy in HBeAg positive chronic hepatitis B

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Peg-interferon improves liver histology

Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine

✍ Monika Van Zonneveld; Pieter E Zondervan; Yilmaz Cakaloglu; Christopher Simon; U 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

HBeAg-positive chronic hepatitis B: why

HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon

✍ George K. K. Lau 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Histological improvement in HBeAg positi

Histological improvement in HBeAg positive chronic hepatitis B patients treated with adefovir dipivoxil

✍ Patrick Marcellin; Zack Goodman; Ting-Tsung Chang; Seng Gee Lim; Myron Tong; Wil 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 165 KB

48 Interferon therapy reduces cirrhosis

48 Interferon therapy reduces cirrhosis and hepatocellular carcinoma in HBeAg positive chronic hepatitis B

✍ S.M. Lin; M.L. Yu; C.M. Lee; R.N. Chien; I.S. Sheen; C.M. Chu; Y.F. Liaw 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Comparison of interferon and lamivudine

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract The aim of this study was to elucidate the long‐term outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history